Thomas joined InfanDx as a Senior Biostatician in April 2021. He has more than 20 years of experience in statistical data analysis for medical devices and clinical studies. He joined InfanDx from Epigenomics AG (Berlin, Germany), where he was member of the product development team that was responsible for the world’s first CE-marked and FDA-approved blood based screening test for colon cancer. At InfanDx he additionally heads up and is responsible for the Software Management Process. Thomas holds a diploma in computer science from the Technical University of Berlin.